Our study further suggested that the re-activation step also triggers CD4+ T to express and exocytose cytotoxic molecules for directly killing MHC-II-restricted tumor cells and MHC-II-non-restricted tumor cells in the close proximity. This evidence concerns the gene CD4 and neoplasm.